Human Molecular Genetics, 2001, Vol. 10, No. 19 2025-2037
© 2001 Oxford University Press
A correlation between the relative predisposition of MHC class II alleles to type 1 diabetes and the structure of their proteins
Dipartimento di Scienze Biomediche e Biotecnologie, University of Cagliari, Via Jenner, Cagliari 09121, Italy, 1Servizio di Diabetologia Pediatrica, Ospedale G.Brotzu, Via Peretti, Cagliari, Italy, 2JDRF/WT Diabetes and Inflammation Laboratory, Cambridge Institute for Medical Research, University of Cambridge, Addenbrookes Hospital, Cambridge CB2 2XY, UK and 3Department of Medicine, University of Birmingham, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK
In human type 1 diabetes (T1D) and in its murine model, the major histocompatibility complex (MHC) class II molecules, human leukocyte antigens (HLA)-DQ and -DR and their murine orthologues, IA and IE, are the major genetic determinants. In this report, we have ranked HLA class II molecule-associated T1D risk in a two-sided gradient from very high to very low. Very low risk corresponded to dominant protection from T1D. We predicted the protein structure of DQ by using the published crystal structures of different allotypes of the murine orthologue of DQ, IA. We discovered marked similarities both within, and cross species between T1D protective class II molecules. Likewise, the T1D predisposing molecules showed conserved similarities that contrasted with the shared patterns observed between the protective molecules. We also found striking inter-isotypic conservation between protective DQ, IA allotypes and protective DR4 subtypes. The data provide evidence for a joint action of the class II peptide-binding pockets P1, P4 and P9 in disease susceptibility and resistance with a main role for P9 in DQ/IA and for P1 and P4 in DR/IE. Overall, these results suggest shared epitope(s) in the target autoantigen(s), and common pathways in human and murine T1D.
+ To whom correspondence should be addressed. Tel: +39 070 6095681; Fax: +39 070 6095558; Email: fcucca@mcweb.unica.it Correspondence may also be addressed to John Todd at: Wellcome Trust/MRC Building, Addenbrookes Hospital, Hills Road, Cambridge CB2 2XY, UK. Tel: +44 1223 762101; Fax: +44 1223 762102; Email: john.todd@cimr.cam.ac.uk
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Huber, F. Menconi, S. Corathers, E. M. Jacobson, and Y. Tomer Joint Genetic Susceptibility to Type 1 Diabetes and Autoimmune Thyroiditis: from Epidemiology to Mechanisms Endocr. Rev., October 1, 2008; 29(6): 697 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Smyth, J. D. Cooper, J. M.M. Howson, N. M. Walker, V. Plagnol, H. Stevens, D. G. Clayton, and J. A. Todd PTPN22 Trp620 Explains the Association of Chromosome 1p13 With Type 1 Diabetes and Shows a Statistical Interaction With HLA Class II Genotypes Diabetes, June 1, 2008; 57(6): 1730 - 1737. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zoledziewska, C. Perra, V. Orru, L. Moi, P. Frongia, M. Congia, N. Bottini, and F. Cucca Further Evidence of a Primary, Causal Association of the PTPN22 620W Variant With Type 1 Diabetes Diabetes, January 1, 2008; 57(1): 229 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ge, J. D. Piganelli, H. M. Tse, S. Bertera, C. E. Mathews, M. Trucco, L. Wen, and W. A. Rudert Modulatory Role of DR4- to DQ8-restricted CD4 T-Cell Responses and Type 1 Diabetes Susceptibility Diabetes, December 1, 2006; 55(12): 3455 - 3462. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Redondo, S. Babu, A. Zeidler, T. Orban, L. Yu, C. Greenbaum, J. P. Palmer, D. Cuthbertson, G. S. Eisenbarth, J. P. Krischer, et al. Specific Human Leukocyte Antigen DQ Influence on Expression of Antiislet Autoantibodies and Progression to Type 1 Diabetes J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1705 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Smyth, J. D. Cooper, C. E. Lowe, S. Nutland, N. M. Walker, D. G. Clayton, and J. A. Todd No Evidence for Association of OAS1 With Type 1 Diabetes in Unaffected Siblings or Type 1 Diabetic Cases. Diabetes, May 1, 2006; 55(5): 1525 - 1528. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Traherne, L. F. Barcellos, S. J. Sawcer, A. Compston, P. P. Ramsay, S. L. Hauser, J. R. Oksenberg, and J. Trowsdale Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15 Hum. Mol. Genet., January 1, 2006; 15(1): 155 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Noso, H. Ikegami, T. Fujisawa, Y. Kawabata, K. Asano, Y. Hiromine, M. Tsurumaru, S. Sugihara, I. Lee, E. Kawasaki, et al. Genetic Heterogeneity in Association of the SUMO4 M55V Variant With Susceptibility to Type 1 Diabetes Diabetes, December 1, 2005; 54(12): 3582 - 3586. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Simmonds and S. C. L. Gough Genetic insights into disease mechanisms of autoimmunity Br. Med. Bull., February 8, 2005; 71(1): 93 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Marrosu, C. Motzo, R. Murru, R. Lampis, G. Costa, P. Zavattari, D. Contu, E. Fadda, E. Cocco, and F. Cucca The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone Hum. Mol. Genet., December 1, 2004; 13(23): 2919 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Motzo, D. Contu, H. J. Cordell, R. Lampis, M. Congia, M. G. Marrosu, J. A. Todd, M. Devoto, and F. Cucca Heterogeneity in the Magnitude of the Insulin Gene Effect on HLA Risk in Type 1 Diabetes Diabetes, December 1, 2004; 53(12): 3286 - 3291. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Smyth, J. D. Cooper, J. E. Collins, J. M. Heward, J. A. Franklyn, J. M.M. Howson, A. Vella, S. Nutland, H. E. Rance, L. Maier, et al. Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus Diabetes, November 1, 2004; 53(11): 3020 - 3023. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Murao, H. Makino, Y. Kaino, E. Konoue, J. Ohashi, K. Kida, Y. Fujii, I. Shimizu, E. Kawasaki, M. Fujiyama, et al. Differences in the Contribution of HLA-DR and -DQ Haplotypes to Susceptibility to Adult- and Childhood-Onset Type 1 Diabetes in Japanese Patients Diabetes, October 1, 2004; 53(10): 2684 - 2690. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Lambert, K. M. Gillespie, G. Thomson, H. J. Cordell, J. A. Todd, E. A. M. Gale, and P. J. Bingley Absolute Risk of Childhood-Onset Type 1 Diabetes Defined by Human Leukocyte Antigen Class II Genotype: A Population-Based Study in the United Kingdom J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 4037 - 4043. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kelemen, P. A. Gottlieb, A. L. Putnam, H. W. Davidson, D. R. Wegmann, and J. C. Hutton HLA-DQ8-Associated T Cell Responses to the Diabetes Autoantigen Phogrin (IA-2{beta}) in Human Prediabetes J. Immunol., March 15, 2004; 172(6): 3955 - 3962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Kelly, M L Rayner, C H Mijovic, and A H Barnett Molecular aspects of type 1 diabetes Mol. Pathol., February 1, 2003; 56(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sidney, M.-F. del Guercio, S. Southwood, and A. Sette The HLA Molecules DQA1*0501/B1*0201 and DQA1*0301/B1*0302 Share an Extensive Overlap in Peptide Binding Specificity J. Immunol., November 1, 2002; 169(9): 5098 - 5108. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bearzatto, H. Naserke, S. Piquer, K. Koczwara, V. Lampasona, A. Williams, M. R. Christie, P. J. Bingley, A.-G. Ziegler, and E. Bonifacio Two Distinctly HLA-Associated Contiguous Linear Epitopes Uniquely Expressed Within the Islet Antigen 2 Molecule Are Major Autoantibody Epitopes of the Diabetes-Specific Tyrosine Phosphatase-Like Protein Autoantigens J. Immunol., April 15, 2002; 168(8): 4202 - 4208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Marrosu, R. Murru, M. R. Murru, G. Costa, P. Zavattari, M. Whalen, E. Cocco, C. Mancosu, L. Schirru, E. Solla, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia Hum. Mol. Genet., December 1, 2001; 10(25): 2907 - 2916. [Abstract] [Full Text] [PDF] |
||||






